Kardigan, Inc.
- KARD
- NASDAQ
- Biotechnology
- Precision Cardiology
- AI Drug Discovery
$12.94
Today −0.69%Quote Oct 19, 2026, 08:00 PM UTC
−22.24%over the last month
Max drawdown −22.2%From 1-month high −22.2%3 months −43.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Kardigan
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
241
Market value
$1.16B
Quote Oct 19
Floor
$12.29
5.1% below price
Resistance
$13.49
4.3% above price
Price vs analyst targets
1 analyst
Lowest target
$25.00Highest target
$40.00
$25.00Highest target
$40.00
- Price $12.94
- Average target $34.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 163% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about KARDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free